October 23, 2025

GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

Vienna, Austria – October 22, 2025 – GalaTek GmbH, a leading innovator in laboratory automation technologies, and a:head bio AG, a pioneering biotech company specializing in human brain organoid research, today announced a strategic collaboration aimed at advancing the automation of brain organoid workflows.

The partnership aims to integrate GalaTek’s advanced robotics and software platforms with a:head bio’s proprietary organoid systems to streamline and scale the production, maintenance, and analysis of human brain organoids. These organoids—miniaturized, lab-grown models of the human brain—are increasingly used to replicate disease-relevant biology and accelerate the development of novel therapeutics.

“Our mission is to industrialize brain organoid technologies for use in high-throughput drug discovery,” said Dr. Joshua Bagley, CSO of a:head bio AG. “By automating key steps in the workflow, we can enhance reproducibility, reduce variability, and significantly increase throughput—critical factors for pharmaceutical applications.”

The collaboration will focus on automating complex processes such as organoid culture, phenotypic screening, and quality control. The resulting platform will support a:head bio’s internal pipeline of disease models and provide scalable solutions for pharma partners seeking to evaluate compounds in human-relevant neural systems.

“a:head bio’s expertise in brain organoid biology is a perfect match for our automation capabilities,” said Dr. Yicheng Liu, General Manager of GalaTek GmbH. “Together, we will deliver robust, modular systems that enable efficient and reproducible workflows tailored to the needs of drug discovery teams.”

The first integrated systems are expected to be deployed in December 2025, marking the beginning of a broader initiative to industrialize brain organoid workflows through end-to-end automation from culture and maintenance to screening and data integration.

Our latest News

discover more
2026 BioTech Breakthrough Honors VectorBuilder With “Overall CGT Solution Provider of the Year”

2026 BioTech Breakthrough Honors VectorBuilder With “Overall CGT Solution Provider of the Year”

Annual awards program recognizes innovation in life sciences and biotechnology worldwide CHICAGO, November 5, 2026 – VectorBuilder, a global leader in gene delivery technologies, today announced it has been named “Overall CGT Solution Provider of the Year” in the sixth annual BioTech Breakthrough Awards, recognizing innovation across the global life sciences and biotechnology industries. VectorBuilder integrates vector […]

Breast Milk for the Youngest Babies: New Milk Bank at Heidelberg University Hospital

Breast Milk for the Youngest Babies: New Milk Bank at Heidelberg University Hospital

The Heidelberg University Hospital (UKHD) recently launched “HeidelMilk,” a breast milk donation bank. It provides premature infants with donated breast milk when their own mothers’ milk supply is insufficient. To mark World Prematurity Day on November 15, the UKHD is introducing this new service. Full Text in German below. Muttermilch für die Kleinsten: Neue Milchbank […]

When Brake Cells Become Killer Cells: Double Honor for DKFZ Researcher Julius Michel

When Brake Cells Become Killer Cells: Double Honor for DKFZ Researcher Julius Michel

Julius Michel, a postdoctoral researcher at the German Cancer Research Center (DKFZ), has received two awards: the Craig Tendler Award for Myeloma Research from the American Society of Hematology – awarded for the first time and accompanied by a $10,000 prize – as well as another award from the society. He has discovered that a […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp